Alnylam Pharmaceuticals
ALNY
ALNY
389 hedge funds and large institutions have $15.4B invested in Alnylam Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 148 increasing their positions, 116 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
10% more capital invested
Capital invested by funds: $14B → $15.4B (+$1.39B)
4% more funds holding
Funds holding: 373 → 389 (+16)
0.55% more ownership
Funds ownership: 92.94% → 93.49% (+0.55%)
Holders
389
Holding in Top 10
7
Calls
$83.9M
Puts
$54.4M
Top Buyers
| 1 | +$219M | |
| 2 | +$142M | |
| 3 | +$64.4M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$52.7M |
| 5 |
Swedbank
Stockholm,
Sweden
|
+$51.2M |
Top Sellers
| 1 | -$137M | |
| 2 | -$95.5M | |
| 3 | -$47.9M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$45.3M |
| 5 |
MC
Maverick Capital
Dallas,
Texas
|
-$28.3M |